Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124339692 | 12433969 | 2 | F | 201605 | 20160622 | 20160603 | 20160706 | EXP | US-BAYER-2016-103292 | BAYER | 53.00 | YR | A | F | Y | 0.00000 | 20160706 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124339692 | 12433969 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 6 MIU, QOD | Y | 103471 | 6 | MIU | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124339692 | 12433969 | 1 | Multiple sclerosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124339692 | 12433969 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124339692 | 12433969 | Aphasia | |
124339692 | 12433969 | Disorientation | |
124339692 | 12433969 | Loss of consciousness | |
124339692 | 12433969 | Malaise | |
124339692 | 12433969 | Memory impairment | |
124339692 | 12433969 | Mental impairment | |
124339692 | 12433969 | Muscular weakness | |
124339692 | 12433969 | Petit mal epilepsy | |
124339692 | 12433969 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124339692 | 12433969 | 1 | 20160415 | 20160518 | 0 |